7Baggers
 valneva’s remarkable financial reversal signals new growth phase  AD HOC NEWS Sat, 15 Nov 2025 05:05:04 GMT
 Valneva SE earnings beat by $0.02, revenue fell short of estimates  Investing.com Nigeria Sat, 15 Nov 2025 00:50:25 GMT
 Valneva SE earnings beat by $0.02, revenue fell short of estimates  Investing.com Fri, 14 Nov 2025 11:10:16 GMT
 valneva’s zika vaccine breakthrough faces commercial hurdles  AD HOC NEWS Thu, 13 Nov 2025 04:59:04 GMT
 published on: 2025-11-12 17:45:22  newser.com Wed, 12 Nov 2025 23:45:22 GMT
 technical reactions to valn trends in macro strategies  news.stocktradersdaily.com Wed, 12 Nov 2025 20:26:02 GMT
 valneva faces critical third quarter report  AD HOC NEWS Wed, 12 Nov 2025 10:41:04 GMT

Valneva SE
(NASDAQ:VALN) 

VALN stock logo

Valneva SE is a French biotech company headquartered in Saint-Herblain, France, developing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden and Vienna, Austria, with other offices in France, Canada and the United States.

Founded: 2012
CEO: Thomas Lingelbach  
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology

Share this website to your friends